Ethics
Featured Topics in Policy & Industry: Climate Policy | Military Defense | Government Policy | | Alternative Fuels | all topics
Filter by: News | Articles | New to Market | Tools & Technology | Videos | Podcasts | Journal Articles | White Papers
Feb 19 | News
Even as America appears ready to begin constructing nuclear power plants again, the effort to downsize nuclear arsenals here and abroad has been revived. American Physical Society experts have published a new report talks about the technical steps necessary to responsibly trim the stockpile.
Jan 26 | News
A handheld XRF analyzer from Bruker is being used to verify and identify surgical steels for implants to be used by a medical non-profit, Surgical Implant Generation Network, during a relief mission in Haiti.
Jan 12 | News
Lead paint and melamine-tainted milk—infamously hazardous products from China—have grabbed the headlines in recent years. But another metal, cadmium, has caught the eye of regulators as the easy-to-work but cancer-causing metal has begun appearing in metallic toys and jewelry.
12/14/2009 | News
Climate research e-mails stolen from a Univ. of East Anglia server amounted to 1 million in total, and a review by the Associated Press showed that apart from a clear effort to shape the message to be drawn from their studies, the most significant finding was that an effort may have been made to avoid sharing scientific data with critics skeptical of global warming.
11/9/2009 | News
Companies that commit fraud can find innovative ways to fudge the numbers, making it hard to tell something is wrong by looking at their financial statements. But a new warning system sees through accounting tricks by evaluating things that are easily...
10/24/2007 | Featured Articles
Corporate research and development has become a global operation, with most large, and even small, companies maintaining and building R&D operations in far-flung offices. U.S.-based IBM, for example, is now said to have more scientists and engineers in India than it has in the U.S. Similarly, a number of large European and Asian pharmaceutical companies have more research resources in the U.S. than they do in their home countries to support the world's largest healthcare market and researcher base.